WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005117933) USE OF PROTEIN HYDROLYSATES FOR THE MANUFACTURE OF A MEDICAMENT FOR PROPHYLAXIS AND/OR TREATMENT OF A DPP-IV MEDIATED CONDITION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/117933    International Application No.:    PCT/EP2005/005757
Publication Date: 15.12.2005 International Filing Date: 24.05.2005
IPC:
A61K 38/01 (2006.01), A61P 3/04 (2006.01), A61P 3/10 (2006.01)
Applicants: CAMPINA NEDERLAND HOLDING B.V. [NL/NL]; 9, Hogeweg, NL-5301 LB Zaltbommel (NL) (For All Designated States Except US).
BOOTS, Jan-Willem, Pieter [NL/NL]; (NL) (For US Only)
Inventors: BOOTS, Jan-Willem, Pieter; (NL)
Agent: BOT, David, Simon, Maria; Nederlandsch Octrooibureau, P.O. Box 29720, NL-2502 LS The Hague (NL)
Priority Data:
04076579.4 27.05.2004 EP
Title (EN) USE OF PROTEIN HYDROLYSATES FOR THE MANUFACTURE OF A MEDICAMENT FOR PROPHYLAXIS AND/OR TREATMENT OF A DPP-IV MEDIATED CONDITION
(FR) UTILISATION D'HYDROLYSATS PROTEIQUES POUR PREPARER UN MEDICAMENT DESTINE A PREVENIR ET/OU TRAITER UN ETAT PATHOLOGIQUE INDUIT PAR DPP-IV
Abstract: front page image
(EN)Disclosed is the use of one or more protein hydrolysates for the manufacture of a medicament, food supplement, beverage or food product for prophylaxis and/or treatment of a DDP-IV mediated condition, like for example obesity, type II diabetes mellitus, autoimmune diseases.
(FR)L'invention a trait à l'utilisation d'un ou plusieurs hydrolysats protéiques pour préparer un médicament, un complément alimentaire, une boisson ou un aliment permettant de prévenir et/ou de traiter un état pathologique induit par DDP-IV, tel que l'obésité, le diabète sucré de type 2, et des maladies auto-immunes.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)